These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 4189485)

  • 1. [Determination of the immunoglobulin type of complement fixing and non-fixing anti-nuclear factors].
    Peltier AP; Strejcek G
    Rev Fr Etud Clin Biol; 1969 Oct; 14(8):787-95. PubMed ID: 4189485
    [No Abstract]   [Full Text] [Related]  

  • 2. Heterogeneity of antinucleolar antibody and IgE antinuclear antibody in patients with systemic rheumatic diseases.
    Miyawaki S; Ritchie RF
    J Immunol; 1974 Oct; 113(4):1346-52. PubMed ID: 4606613
    [No Abstract]   [Full Text] [Related]  

  • 3. Complement fixing activity and immunoglobulin classes of antinuclear antibodies occurring in systemic lupus erythematosus and rheumatoid arthritis.
    Massonnet-Castel S; Cassuto JP; Rioche M; Mucchielli A; Masseyeff R
    Biomedicine; 1981 Feb; 34(1):40-6. PubMed ID: 6971657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-fixing activity of antinuclear antibodies induced by procaine amide treatment.
    Klajman A; Farkas R; Ben-Efraim S
    Isr J Med Sci; 1973 May; 9(5):627-30. PubMed ID: 4123966
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic lupus erythematosus. Studies of the antibodies bound to skin.
    Landry M; Sams WM
    J Clin Invest; 1973 Aug; 52(8):1871-80. PubMed ID: 4578295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement-fixing granulocyte-specific antinuclear factors in neutropenic cases of rheumatoid arthritis.
    Wiik A; Munthe E
    Immunology; 1974 Jun; 26(6):1127-34. PubMed ID: 4604253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antinuclear antibodies in disseminated lupus erythematosus and other connective tissue diseases].
    Velasco M; Losada M; Losada A; Ramirez G
    Rev Med Chil; 1968 Aug; 96(8):517-21. PubMed ID: 4915546
    [No Abstract]   [Full Text] [Related]  

  • 8. Antinuclear antibody induced by procainamide. A prospective study.
    Blomgren SE; Condemi JJ; Bignall MC; Vaughan JH
    N Engl J Med; 1969 Jul; 281(2):64-6. PubMed ID: 4182059
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunoglobulins and autoantibodies. (Characterization studies of some autoantibodies and clinical observations)].
    Bonomo L
    G Mal Infett Parassit; 1966 Dec; 18(12):Suppl:993-1004. PubMed ID: 4173183
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antinuclear factors in rheumatoid arthritis (RA): differentiation of the binding pattern, the H and L chains and demonstration of complement fixation by means of indirect immunofluorescence].
    Dreher R
    Verh Dtsch Ges Rheumatol; 1978; 5():103-6. PubMed ID: 100982
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative studies of the demonstration of antinuclear factors by immunofluorescence and antiglobulin consumption tests].
    Schmidt K; Mueller-Eckhardt C; Becker W
    Verh Dtsch Ges Rheumatol; 1969; 1():251-8. PubMed ID: 4934585
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic lupus erythematosus and the crithidia luciliae immunofluorescent test. A comparative study with an adapted Farr radioimmunoassay.
    Whitehouse IJ; Fehr K; Wagenhäuser FJ
    Z Rheumatol; 1983; 42(1):28-35. PubMed ID: 6342296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological diagnosis of rheumatoid arthritis and systemic lupus erythematosus.
    Wager O
    Ann Clin Res; 1975 Jun; 7(3):168-82. PubMed ID: 1103712
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of antinuclear antibodies, anti-DNA antibodies, C 3 complement factor and IgG in lupus erythematosus and rheumatoid arthritis].
    Lehmann C; Hurtado R; Valdivieso M; Godoy G; Sorensen R
    Rev Med Chil; 1972; 100(5):485-9. PubMed ID: 4114175
    [No Abstract]   [Full Text] [Related]  

  • 15. [Heterogenicity of antinuclear immunoglobulins: simultaneous demonstration of classes and types of nuclear fluorescence with the "2-layer" and "3-layer" immunofluorescence test].
    Zitnan D; Cebecauer L; Saradinová M; Misurová V
    Fysiatr Revmatol Vestn; 1969 Apr; 47(2):54-62. PubMed ID: 4181078
    [No Abstract]   [Full Text] [Related]  

  • 16. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus].
    Peltier AP
    Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383
    [No Abstract]   [Full Text] [Related]  

  • 17. Cold-insoluble complexes and complement levels in systemic lupus erythematosus.
    Stastny P; Ziff M
    N Engl J Med; 1969 Jun; 280(25):1376-81. PubMed ID: 4181609
    [No Abstract]   [Full Text] [Related]  

  • 18. [Some aspects of humoral and cellular immunity in acute viral hepatitis. Diagnostic and prognostic prospects].
    Fiaschi E; Naccarato R; Fagiolo U; Farini R
    Rev Med Chir Mal Foie; 1970; 45(4):215-26. PubMed ID: 4194748
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lupus erythematosus disseminatus: model of an autoimmune disease?].
    Mueller-Eckhardt C
    Dtsch Med Wochenschr; 1969 May; 94(19):1024-31. PubMed ID: 4181103
    [No Abstract]   [Full Text] [Related]  

  • 20. [Humoral immune phenomena in rheumatoid arthritis].
    Felsch G
    Allerg Immunol (Leipz); 1974-1975; 20-21(3):265-73. PubMed ID: 4283448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.